MedPath

Invasive PGT-A Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection

Recruiting
Conditions
Aneuploidy
Infertility
Chromosome Abnormality
Interventions
Diagnostic Test: embryo selection
Registration Number
NCT05547555
Lead Sponsor
Assisting Nature
Brief Summary

This is a prospective randomised study of the evaluation of the clinical IVF results after invasive PGT-A embryo selection versus Non-invasive PGT-A assisted embryo selection in subfertile women.

Detailed Description

A randomized prospective study focusing on subfertile women undergoing IVF treatment followed by embryo transfer on the blastocyst stage.

Women assigned to group A proceed to embryo transfer, after invasive PGT-A embryo selection, while women of group B after non-invasive PGT-A assisted embryo selection.

IVF outcomes, regarding the success rate of the trasnfer and the time required to achieve conception is studied in both groups.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Women who followed IVF treatment
  • 40 years old or older
  • Single embryo transfer
  • blastocyst stage cultured embryos
Exclusion Criteria
  • women under the age of 40 years
  • not blastocyst transfer (transfers performed at earlier embryo stage)
  • double embryotransfer
  • women who had embryotransfer according to morphological criteria women whose embryos were not time-lapse monitored

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
INVASIVE PGT-Aembryo selectionWomen who proceed to embryo transfer after invasive PGT-A embryo selection.
NON INVASIVE PGT-Aembryo selectionWomen who proceed to embryo transfer after non- invasive PGT-A embryo selection.
Primary Outcome Measures
NameTimeMethod
Embryotransfers to conceiveUp to the embryotransfer of the last enrolled patient (Dec 2023)

The number of the embryotransfers required for women to conceive

Time interval to conceiveUp to the pregnancy test after the last embryo transfer of an enrolled patient (Jan 2024)

Time interval required for women to conceive (in months): from day of first embryotransfer to positive hCG test

Cumulative Live Birth RateUp to 38 weeks after the embryo transfer

Cumulative Live Birth Rate achieved after one OPU treatment

Secondary Outcome Measures
NameTimeMethod
DaC rateduring pregnancy according to Greek Law

The rate of the dilation and curretage rate in both groups

Abortion rateUp to 2nd trimester miscarriages

The spontaneous miscarriage of women in both groups

Trial Locations

Locations (1)

Assisting Nature

🇬🇷

Thessaloníki, Thessaloniki, Greece

© Copyright 2025. All Rights Reserved by MedPath